GBM rapidly developing de novo are classified as primary GBM, while GBM developing from low-grade astrocytoma are classified as secondary GBM and show IDH1 mutations (Ohgaki and Kleihues, 2013). This evidence concerns the gene IDH1 and glioblastoma.